Cases & Deals

  • Home
  • Practices
  • EVQLV builds patent portfolio directed to AI-enabled drug discovery technologies

Share

EVQLV builds patent portfolio directed to AI-enabled drug discovery technologies

January 2020

Client(s) EVQLV, Inc.

Jones Day is representing EVQLV, Inc., a New York based, venture-backed startup, in the development and prosecution of a portfolio of patents directed to AI-enabled drug discovery technologies.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.